Adipokine signaling networks—especially leptin, adiponectin, chemerin, and visfatin—emerged in concert with basic pathophysiological processes, including insulin resistance, fibrosis, and bariatric surgery as a therapeutic intervention during the middle period (2013–2017) [44,60]. The gene discussed is RARRES2; the disease is Insulin resistance.